Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

LatGYNious pelvic mesh for treating pelvic organ prolapse

Official title: Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Lateral Suspension (LatGYNious)

Run by A.M.I. Agency for Medical Innovations GmbH · NCT07066761 · Data updated 2026-11-12

This study will try the LatGYNious preformed mesh during laparoscopic lateral suspension surgery to see if it improves prolapse symptoms in women who need surgical repair.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment85 (estimated)
SponsorA.M.I. Agency for Medical Innovations GmbH
Industry-sponsored
Drugs / interventionsimmunotherapy
Locations5 sites (Sankt Johann in Tirol, Tyrol and 4 other locations)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedDecember 2027
Study endsApril 2028
Registry record updatedJuly 28, 2026
Trial IDNCT07066761 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women with symptomatic pelvic organ prolapse (grade 2 or higher) who are eligible for laparoscopic surgical repair and can attend follow-up visits.

Probably not a fit

Patients who previously had a mesh implant for prolapse, have known polypropylene allergy, active relevant cancer, pregnancy, or contraindications to the device are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The device is a preformed pelvic mesh that combines an ultra-light, elastic polypropylene body with reinforced mesh arms designed for strong lateral fixation. Patients with symptomatic pelvic organ prolapse grade 2 or higher who are candidates for surgical repair will receive laparoscopic lateral suspension using the LatGYNious implant, with the mesh posterior portion removed if uterus preservation is planned. The study will collect clinical data on safety outcomes and anatomical and functional performance over scheduled follow-up visits. The goal is to characterize complication rates, fixation strength, and prolapse recurrence after implantation.

Why it matters

Potential benefit: If successful, the LatGYNious mesh could provide firmer, longer-lasting support and lower recurrence of prolapse after surgery.

How similar studies have gone: Similar mesh-based repairs and laparoscopic lateral suspension procedures have shown improved anatomical outcomes in some series, but results are mixed because mesh-related complications have also been reported.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Symptomatic prolapse in one of the 3 compartments from grade 2 with or without uterus
* Subject is candidate for a surgical treatment of pelvic organ prolapse
* Subject is willing and able to cooperate with follow-up examinations
* Subject has been informed of the study procedures and the treatment and has signed an informed consent form and provided authorization to use and disclose information for research purposes.

Exclusion Criteria:

* Previous surgical treatment with a mesh implant for pelvic organ prolapse (mesh implant in anterior or posterior compartment)
* Active immunotherapy which may negatively affect the treatment with a surgical mesh
* Active cancer of the vagina / cervix / rectum
* . known or suspected hypersensitivity to Polypropylene
* Pregnancy
* participation in another study at the same time
* Unable to understand study requirements or is unable to comply with follow-up schedule
* Contraindicated according to the instruction for use of the device

Where it's running

  • BZK St. Johann in Tirol
    Sankt Johann in Tirol, Tyrol, Austria
    Recruiting
  • Universitätsklinikum Wiener Neustadt, Klinische Abteilung für Gynäkologie und Geburtshilfe
    Wiener Neustadt, Austria
    Recruiting
  • Universitätsklinik Brandenburg a.d. Havel, Klinik für Frauenheilkunde und Geburtshilfe
    Brandenburg, Germany
    Not yet recruiting
  • Krankenhaus St. Joseph-Stift Bremen
    Bremen, Germany
    Not yet recruiting
  • Medizincampus Bodensee - Klinik Tettnang
    Tettnang, Germany
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.